Form 4: Actinium Pharmaceuticals Director Cancels Stock Options
SEC Form 4
Director Ajit Shetty cancels multiple stock options in Actinium Pharmaceuticals, effective March 31, 2025, as per an Option Cancellation and Release Agreement.
Summary
- On April 2, 2025, a Form 4 filing revealed that Ajit Shetty, a director at Actinium Pharmaceuticals, cancelled several stock options.
- The cancellation, effective March 31, 2025, was made pursuant to an Option Cancellation and Release Agreement between Shetty and Actinium Pharmaceuticals.
- The cancelled options had various exercise prices and expiration dates, ranging from $4.96 to $47.4 per share.
- The total number of options cancelled amounted to 174,484 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of an insider transaction (stock option cancellation). It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend in the pharmaceutical industry.
Stakeholder Impact
- The cancellation of stock options could have a minor dilutive effect on existing shareholders, although the impact is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Effective date of stock option cancellation. |
| 03/28/2027 | Expiration date of one of the cancelled stock options. |
| 07/13/2028 | Expiration date of one of the cancelled stock options. |
| 07/12/2029 | Expiration date of one of the cancelled stock options. |
| 08/12/2030 | Expiration date of one of the cancelled stock options. |
| 09/01/2031 | Expiration date of one of the cancelled stock options. |
| 07/01/2032 | Expiration date of one of the cancelled stock options. |
| 12/28/2033 | Expiration date of one of the cancelled stock options. |
| 04/02/2025 | Date of Form 4 filing. |
Keywords
Actinium Pharmaceuticals, Form 4, Stock Options, Ajit Shetty, Director, Cancellation, ATNM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.